WWE Hall of Famer Ric Flair is cancer free once again. Flair announced on Tuesday that he's completed his treatment for ...

Replimune said the agency had issued a complete response letter regarding the company’s biologics license application for RP1 ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Replimune Group, Inc. (NASDAQ:REPL) saw its stock nosedive 77% on Tuesday after the company revealed it received a Complete ...

BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the ...

Replimune Group Inc. shares sank to their lowest point ever after US regulators rejected a skin cancer treatment from the ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

Investing.com -- Replimune Group, Inc. (NASDAQ: REPL) stock plunged 77% after the company announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) ...

Novel multiomics tumor profiling demonstrates feasibility and clinical benefit in guiding melanoma treatment decisions, a ...

Melanoma is the deadliest form of skin cancer, but it's treatable if caught early. Like many others, these four women knew ...

Teddi Mellencamp explains how parenting has changed for her since going through treatment for cancer. The 'Real Housewives of ...

Treatment for melanoma is based on the stage of the cancer and other things, such as your overall health. The main treatment is: Surgery: The doctor removes the melanoma and a border of normal tissue.